Virtus ETF Advisers LLC lowered its stake in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 11.5% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 12,784 shares of the biotechnology company’s stock after selling 1,654 shares during the period. Virtus ETF Advisers LLC’s holdings in Enanta Pharmaceuticals were worth $143,000 […]